DOT publishes guidance for updating drug and alcohol policies in light of recent opioid testing update
Tags : DOT Compliance
On Jan. 1, 2018, the U.S. Department of Transportation (DOT) will expand its current panel to require testing for semi-synthetic opioids. The semi-synthetic drugs that must be tested for are: hydrocodone, hydromorphone, oxymorphone, and oxycodone.
To assist DOT-regulated employers with updating their drug and alcohol policies to comply with these new requirements, the DOT published a guidance notice on Dec. 1. The guidance can be found here.
For more information on the DOT’s updated drug testing panel, please see our previous News to Note
Source: Jackson Lewis P.C., 12/4/2017
We cannot express enough how much we have enjoyed working with BIG! It has really benefitted our processing and ease of doing business!
I enjoy collaborating with BIG, and know that if I have to reach out with a question/concern, a positive attitude with a willingness to find resolve is on the other side of an email or a phone call.
You have been the most professional and most helpful business partner that I have ever been associated with — always there to assist us and with rapid turnaround times.
I am confident whenever we add a product with your company that I will have a good experience.
We have received superior service and we know this is what you and your team strive for. We are grateful for the dedication, level of professionalism and effort shown.